Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 15, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.
Journal: JCO precision oncology
Published: June 12, 2026
Cancer Screening and Barriers to Screening Among Unhoused Individuals in Rhode Island.
Journal: Rhode Island medical journal (2013)
Published: February 25, 2026
Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets.
Journal: Molecular aspects of medicine
Published: February 12, 2026
Corrigendum to "Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis" [Cancer Lett. 481 (2020) 63-75].
Journal: Cancer letters
Published: November 21, 2025
CRE25-047: Avapritinib Induced Pseudoprogression in a Gastrointestinal Stromal Tumor With a PDGFRA Exam 18 842 Mutation.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT.
Journal: Oncotarget
Published: March 27, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Journal: Oncotarget
Published: March 12, 2025
IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge.
Journal: Frontiers in oncology
Published: January 06, 2025
Acquired resistance to molecularly targeted therapies for cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 25, 2024
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
Journal: Journal of immunotherapy and precision oncology
Published: March 14, 2024
Last Updated: 09/26/2026